Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2016 MASCC/ESMO共识建议：高催吐风险化疗恶心呕吐的预防（更新）

2016-07-22 癌症支持疗法多国学会 Support Care Cancer. 2016 Jul 22.

化疗恶心呕吐

2016年7月，癌症支持疗法多国学会(MASCC)联合欧洲肿瘤内科学会(ESMO)共同发布了高催吐风险化疗恶心呕吐的预防共识建议，文章主要总结了接受高催吐风险化疗的成恶心呕吐的预防建议，共识建议是对2009年止吐剂共识的更新。

中文标题：

2016 MASCC/ESMO共识建议：高催吐风险化疗恶心呕吐的预防（更新）

英文标题：

2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy.

发布机构：

癌症支持疗法多国学会

发布日期：

2016-07-22

简要介绍：

2016年7月，癌症支持疗法多国学会(MASCC)联合欧洲肿瘤内科学会(ESMO)共同发布了高催吐风险化疗恶心呕吐的预防共识建议，文章主要总结了接受高催吐风险化疗的成恶心呕吐的预防建议，共识建议是对2009年止吐剂共识的更新。


制定者： 
癌症支持疗法多国学会(MASCC,Multinational Association of Supportive Care in Cancer)
欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology)


相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 MASCC/ESMO共识建议：高催吐风险化疗恶心呕吐的预防（更新）)] GetToolGuiderByIdResponse(projectId=1, id=f33a21c0012a308d, title=2016 MASCC/ESMO共识建议：高催吐风险化疗恶心呕吐的预防（更新）, enTitle=2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy., guiderFrom=Support Care Cancer. 2016 Jul 22., authorId=null, author=, summary=2016年7月，癌症支持疗法多国学会(MASCC)联合欧洲肿瘤内科学会(ESMO)共同发布了高催吐风险化疗恶心呕吐的预防共识建议，文章主要总结了接受高催吐风险化疗的成恶心呕吐的预防建议，共识建议是对2009年止吐剂共识的更新。, cover=, journalId=null, articlesId=null, associationId=993, associationName=癌症支持疗法多国学会, associationIntro=MASCC是癌症支持疗法多国学会的缩写，是一涉及癌症支持疗法的多学科的国际性组织。成员来自各大洲的60多个国家。MASCC成立于1990年，该组织致力于对各期癌症病人支持疗法各个方面的研究及教育。MASCC的工作目标是通过研究及科学认识的交流，提高支持疗法的专业水平。, copyright=0, guiderPublishedTime=Fri Jul 22 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年7月，癌症支持疗法多国学会(MASCC)联合欧洲肿瘤内科学会(ESMO)共同发布了高催吐风险化疗恶心呕吐的预防共识建议，文章主要总结了接受高催吐风险化疗的成恶心呕吐的预防建议，共识建议是对2009年止吐剂共识的更新。<div><br></div><div><span style="font-weight: bold;">制定者： </span></div><div>癌症支持疗法多国学会(MASCC,Multinational Association of Supportive Care in Cancer)</div><div>欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology)</div><div><br></div><div><br></div>, tagList=[TagDto(tagId=282, tagName=化疗), TagDto(tagId=10113, tagName=恶心), TagDto(tagId=408, tagName=呕吐)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3622, appHits=116, showAppHits=0, pcHits=2015, showPcHits=1890, likes=119, shares=2, comments=2, approvalStatus=1, publishedTime=Mon Jul 25 13:01:53 CST 2016, publishedTimeString=2016-07-22, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Jul 25 13:01:53 CST 2016, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 23:53:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 MASCC/ESMO共识建议：高催吐风险化疗恶心呕吐的预防（更新）)])
2016 MASCC/ESMO共识建议：高催吐风险化疗恶心呕吐的预防（更新）
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=99988, encodeId=682d99988b6, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:06:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99989, encodeId=33e599989b8, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:06:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=99988, encodeId=682d99988b6, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:06:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99989, encodeId=33e599989b8, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:06:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续学习

    0

Baidu
map
Baidu
map
Baidu
map